Details of the Drug Reposition

General Information of This Drug (ID: DMEZ2KH)

Drug Name
Ocrelizumab   DMEZ2KH
Synonyms Ocrelizumab (USAN); Ocrelizumab (genetical recombination); Ocrelizumab (genetical recombination) (JAN)
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diffuse large B-cell lymphoma DISSACK3 2A81 Approved [1]
Multiple sclerosis DISB2WZI 8A40 Approved [2]
------------------------------------------------------------------------------------

References

1 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018